RELMADA THERAPEUTICS, INC. (RLMD) Nonoperating Income (Expense) USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Relmada Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2013 to 2024.
  • Relmada Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $1.16 M, a 36.7% decline year-over-year.
  • Relmada Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $4.24 M, a 43.4% decline year-over-year.
  • Relmada Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $4.91 M, a 16.8% increase from 2022.
  • Relmada Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $4.21 M.
  • Relmada Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$48.3 K, a 103% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.24 M $1.16 M -$672 K -36.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $4.91 M $1.66 M +$906 K +120% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $4 M $691 K +$1.37 M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $2.63 M $724 K -$4.85 M -87% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $7.49 M $1.83 M +$3.28 M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $4.21 M $758 K +$954 K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $3.25 M -$682 K -$729 K -1537% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $3.98 M $5.58 M +$5.67 M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$1.69 M -$1.45 M -$1.64 M -862% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$48.3 K -$196 K -$357 K -221% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $309 K $47.4 K -$234 K -83.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $542 K -$90.1 K -$1.73 M -105% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $2.27 M $190 K +$889 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.38 M $161 K +$124 K +334% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 $1.26 M $281 K +$243 K +641% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1.01 M $1.64 M +$1.63 M +12400% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$611 K -$699 K -$715 K -4485% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $104 K $37.1 K +$3.69 M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-24
Q3 2019 -$3.58 M $37.9 K +$1.01 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$4.59 M $13.1 K +$1.43 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$6.02 M $15.9 K +$668 K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$6.69 M -$3.65 M -$3.68 M -12586% Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-13
Q3 2018 -$3.01 M -$969 K -$968 K -116630% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$2.04 M -$1.42 M Apr 1, 2018 Jun 30, 2018 10-KT 2020-03-26
Q1 2018 -$652 K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $29.2 K Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-13
Q3 2017 -$830* Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q1 2015 $2.1 M -$5.1 M -70.8% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-15
Q4 2014 $9.84 M +$9.95 M Oct 1, 2014 Dec 31, 2014 10-Q 2015-02-13
Q3 2014 -$26.1 M -$25 M -2311% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-07
Q1 2014 $7.21 M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$112 K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-13
Q3 2013 -$1.08 M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.